Harvest, Verano end US$850M tie-up, citing challenging market conditions 

One of the biggest planned cannabis M&A deals is no more. Harvest Health & Recreation's US$850 million deal for Verano Holdings is not happening after the company's mututally agreed to end the transaction. Harvest said in a statement that the process of closing the deal – which was first announced in March, 2019 – was hindered by numerous delays, including getting regulatory approvals from state and municipal authorities to transfer licences and a dearth of available capital for the legal pot industry. Earlier this month, Harvest announced that its executive chairman Jason Vedadi, one of the key architects of the Verano deal, would step down from his role, with Harvest's CEO Steve White taking on his responsibilities. 

TGOD to press pause on Quebec facility, temporarily lay off 30 staff 

Another Canadian cannabis company is pulling back its operations amid financial concerns brought forth from the COVID-19 pandemic. This time it's The Green Organic Dutchman which plans to postpone production at its facility in Valleyfield, Que., temporarily lay off staff and reduce salaries for both salaried workers and certain executives. A company spokesperson said that 30 staff in Quebec are affected by the announcement. TGOD said it spent $229 million building its Valleyfield facility before today's announcement. Jefferies LLP analyst Owen Bennett said TGOD's decision not to operate the facility is a "gross misallocation of capital" by the company's management.   

Shares of MediPharm Labs decline after medical oil product announcement 

MediPharm Labs was a rare decliner on the Toronto Stock Exchange on Thursday after investors soured on the company's plans to start selling branded CBD products. MediPharm said in a statement that the company will begin selling a CBD oil for medical patients and expects to launch other branded products in the next several weeks. MediPharm Labs was a rare decliner on the Toronto Stock Exchange on Thursday after investors soured on the company's plans to start selling branded CBD products. MediPharm said in a statement that the company will begin selling a CBD oil for medical patients and expects to launch other branded products in the next several weeks. Canaccord Genuity analyst Kimberly Hedlin said in a report that the company's decision to launch a branded product is “a logical move" to strengthen its domestic business while it looks for opportunities in international markets. 

WeedMD appoints new CFO; union drive attracts company's workers

Toronto-based cannabis producer WeedMD said it hired a new chief financial officer on Thursday, appointing Lincoln Greenidge to replace Nichola Thompson. Thompson, who is one of a handful of female C-level executives in the cannabis sector, will be formally stepping down at the end of April. Greenidge comes to WeedMD from a career in the mining sector, most recently at LSC Lithium. Elsewhere at WeedMD, company staff have been signing union cards with the United Food and Commercial Workers in a potential unionization effort, according to a report in The London Free Press

Editor's Note: A previous version of this story incorrectly stated a Canaccord Genuity analyst report said MediPharm Labs was shifting its business away from international markets. BNN Bloomberg regrets this error. 



US$574.1 million

-- The amount of combined cannabis sales in Arizona, California, Colorado, Nevada and Oregon, according to BDS Analytics. The monthly sales figure is up 14.8 per cent from January 2019, the firm said. 



Embedded Image

Cannabis Canada is BNN Bloomberg’s in-depth series exploring the stunning formation of the entirely new — and controversial — Canadian recreational marijuana industry. Read more from the special series here and subscribe to our Cannabis Canada newsletter to have the latest marijuana news delivered directly to your inbox every day.